期刊文献+

顺氯氨铂在肿瘤患者体内的药代动力学研究

Pharmakokinetic Studies of Cisplatin in Patients with Neoplastic Disease
暂未订购
导出
摘要 本文报道顺氯氨铂在6例肿瘤患者体内的药代动力学参数及尿药排泄量。顺氯氨铂80mg/m^2静脉滴注,采用衍生化高效液相色谱法测定血药浓度和尿药浓度。结果表明顺氯氨铂在血浆中的衰减为二室开放模型,t(1/2)α为0.44h,t(1/2)β为21.10h,给药后7、24h和5天内的尿药排泄量,分别为给药量的10~19%,11~20%,14~25%。提示为避免蓄积中毒,临床用药疗程间隔时间不宜短于2~2.5月。 Plasma and urine concentration of cisplatin were monitored in 6 male patients after 80mg/m^2 of cisplatin by 1 h infusions. Cisplatin was measured by derivative chromatography, high pressure liquid. Plasma levels of cisplatin decayed in a biphase mode, with an initial half-life of 17 to 36 min and a secondary phase ranging from 18 to 23 h. Urinary excretion was incomplete,10-19% of dose was excreted in the first 7h. By 24 h, only 11-20% was excreted, after 5 days, only 14-25% was recovered. It is recommended that courses of cisplatin be administered no more frequently than every 2 to 2.5 months to reduce the risk of cumulative toxicity.
出处 《贵阳医学院学报》 CAS 1992年第2期100-103,共4页 Journal of Guiyang Medical College
关键词 抗癌药 顺氯氨铂 药代动力学 cisplatin pharmacokinetics chromatography high pressure liquid
  • 相关文献

参考文献2

二级参考文献1

  • 1彭彬,中国临床药理学杂志,1987年,3卷,1期,1页

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部